Adoption of commercial biotech crops in Africa
Adoption of commercial biotech crops in Africa
复制标题
DOI：
--
复制
发表时间：
2011
期刊：
影响因子：
--
通讯作者：
A. Adenle;Minato Mirai
中科院分区：
文献类型：
--
作者：
A. Adenle;Minato Mirai
在非洲，作物生物技术的商业采用率很低。在全世界25个生产转基因作物的国家中，只有南非、布基纳法索和埃及等三个非洲国家生产商业转基因作物。本文回顾了生物安全法规的现状和三个国家的商业化生产的转基因作物在非洲使用的相关文件的集合。报告显示，这三个非洲国家的转基因作物生产正在稳步增长，特别是在南非。在包括非洲在内的所有转基因作物生产国，研究结果表明，转基因作物在社会经济贡献和创造友好环境方面都有好处。但是，资源有限、生物安全和基础设施不足仍然是非洲面临的主要挑战。作物生物技术有潜力提高农产品的质量和产量，并确保非洲的充分营养和粮食安全。
Commercial adoption of crop biotechnology in Africa is very low. Of 25 biotech crops producing countries world-wide, only three African countries like South Africa, Burkina Faso and Egypt are producing commercial biotech crops. This paper reviews the status of biosafety regulation and three countries with commercial production of biotech crops in Africa using a collection of relevant papers. The reports show that biotech crops production in those three African countries are growing steadily particularly in South Africa. In all the biotech crops producing countries including Africa, the results demonstrate that biotech crops have benefits in terms of socio- economic contribution and creating friendly environment. But limited resources, biosafety and inadequate infrastructure still remain major challenges in Africa. Crop biotechnology has potentials for improving qualities and yields of farm produce and ensuring adequate nutrition and food security in Africa.